Eli Lilly’s Alzheimer’s Drug Shows Promise in Small Trial – The New York Times

  1. Eli Lilly’s Alzheimer’s Drug Shows Promise in Small Trial  The New York Times
  2. Lilly hails Alzheimer’s win with donanemab, boasting ‘significant slowing of decline’  FierceBiotech
  3. Lilly says Alzheimer’s drug slows clinical decline in mid-stage trial  Reuters
  4. Lilly Alzheimer’s Drug Helped Patients in Small Trial  The Wall Street Journal
  5. Lilly’s Donanemab Slows Clinical Decline of Alzheimer’s Disease in Positive Phase 2 Trial  PRNewswire
  6. View Full Coverage on Google News

Go to News Source